Schedule 13D ownership disclosure
PetLife Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 71639B105
Event date: 2017-03-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 644,000
- Percent of class
- 1.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-17-008152
- Form type
- SC 13D
- Filer
- Langley Richard H.
- CIK
- CIK 1215323
- Filed
- Jul 25, 2017
- Reporting period
- Mar 03, 2017
- Description
- Schedule 13D beneficial ownership